DCA Vantage™ Microalbumin/Creatinine Reagent Cartridges

Quantitative measurement of albumin, creatinine and albumin/creatinine ratio in urine.

The DCA Vantage™ Microalbumin/Creatinine Reagent Cartridge is designed to quantitatively measure low concentrations of albumin (microalbuminuria), creatinine, and the albumin/creatinine ratio in urine and must be used in conjunction with the DCA Vantage™ Analyzer.

The method is designed for testing random, overnight, or timed specimens with results available to the patient within seven minutes. Testing for microalbuminuria (low concentrations of albumin in the urine) is recommended in patients with insulin-dependent diabetes mellitus (IDDM) as well as patients with non-insulin-dependent diabetes mellitus (NIDDM).

    • Detect early kidney disease co-morbidity.
    • Albumin, Creatinine, and Albumin-to-Creatinine (A:C) ratio from a urine specimen in 7 minutes to report a quantitative protein status with automatic creatinine adjustment.
    • Onboard GFR calculator indexes kidney function.


Microalbumin/Creatinine (urine): Single test reports all three results for:

    • Albumin: 5 to 300 mg/L
    • Creatinine: 1.3 to 44.2 mmol/L (15 to 500 mg/dL)
    • Albumin-to Creatinine Ratio: 0.11 to 226 mg/mmol (1 to 2000 mg/g)

Intended Use

The DCA Vantage™ Microalbumin/Creatinine assay is intended for professional in vitro diagnostic use at the point of care.